Major Histocompatibility Complex (MHC) Tetramer - Global and China Top Players Market Share and Ranking 2025- YH Research

Home > Reports >New Technology > Major Histocompatibility Complex (MHC) Tetramer - Global and China Top Players Market Share and Ranking 2025

Major Histocompatibility Complex (MHC) Tetramer - Global and China Top Players Market Share and Ranking 2025

Publication Date: 2025-08-12
Report Id: 1883907
Industry: New Technology
Report Page: 91
Chart: 100

PDF Download

Publication Date: 2025-08-12
Report Id: 1883907
Industry: New Technology
Report Page: 91
Chart: 100

PDF Download

A research report provider that focuses on identifying industry pain points and solving core problems for companies！

Table of Contents
Description
Table of Figures
Need a Quote?

1 Market Overview
1.1 Major Histocompatibility Complex (MHC) Tetramer Definition
1.2 Global Major Histocompatibility Complex (MHC) Tetramer Market Size and Forecast
1.3 China Major Histocompatibility Complex (MHC) Tetramer Market Size and Forecast
1.4 Share of China Major Histocompatibility Complex (MHC) Tetramer Market with Respect to the Global Market
1.5 Major Histocompatibility Complex (MHC) Tetramer Market Size: China VS Global Growth Rate, 2020-2031
1.6 Major Histocompatibility Complex (MHC) Tetramer Market Dynamics
1.6.1 Major Histocompatibility Complex (MHC) Tetramer Market Drivers
1.6.2 Major Histocompatibility Complex (MHC) Tetramer Market Restraints
1.6.3 Major Histocompatibility Complex (MHC) Tetramer Industry Trends
1.6.4 Major Histocompatibility Complex (MHC) Tetramer Industry Policy

2 Global Leading Players and Market Share
2.1 By Revenue of Major Histocompatibility Complex (MHC) Tetramer, Global Market Share by Company, 2020-2025
2.2 Global Major Histocompatibility Complex (MHC) Tetramer Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.3 Global Major Histocompatibility Complex (MHC) Tetramer Concentration Ratio
2.4 Global Major Histocompatibility Complex (MHC) Tetramer Mergers & Acquisitions, Expansion Plans
2.5 Global Major Histocompatibility Complex (MHC) Tetramer Major Companies Product Type
2.6 Head Office and Area Served of Key Players

3 China Leading Players, Market Share and Ranking
3.1 By Revenue of Major Histocompatibility Complex (MHC) Tetramer, China Market Share by Company, 2020-2025
3.2 China Major Histocompatibility Complex (MHC) Tetramer Major Histocompatibility Complex (MHC) Tetramer Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis
4.1 Major Histocompatibility Complex (MHC) Tetramer Industry Chain
4.2 Major Histocompatibility Complex (MHC) Tetramer Upstream Analysis
4.2.1 Major Histocompatibility Complex (MHC) Tetramer Core Raw Materials
4.2.2 Main Manufacturers of Major Histocompatibility Complex (MHC) Tetramer Core Raw Materials
4.3 Midstream Analysis
4.4 Downstream Analysis
4.5 Major Histocompatibility Complex (MHC) Tetramer Production Mode
4.6 Major Histocompatibility Complex (MHC) Tetramer Procurement Model
4.7 Major Histocompatibility Complex (MHC) Tetramer Industry Sales Model and Sales Channels
4.7.1 Major Histocompatibility Complex (MHC) Tetramer Sales Model
4.7.2 Major Histocompatibility Complex (MHC) Tetramer Typical Distributors

5 Sights by Type
5.1 Major Histocompatibility Complex (MHC) Tetramer Classification
5.1.1 MHC-I
5.1.2 MHC-II
5.2 by Type, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value & CAGR, 2020 VS 2024 VS 2031
5.3 by Type, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2020-2031

6 Sights by Application
6.1 Major Histocompatibility Complex (MHC) Tetramer Segment by Application
6.1.1 Cancer research
6.1.2 Virus research
6.1.3 Bacteria research
6.1.4 Other
6.2 by Application, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value & CAGR, 2020 VS 2024 VS 2031
6.3 by Application, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2020-2031

7 Sales Sights by Region
7.1 By Region, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2020 VS 2024 VS 2031
7.2 By Region, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2020-2031
7.3 North America
7.3.1 North America Major Histocompatibility Complex (MHC) Tetramer Market Size & Forecasts, 2020-2031
7.3.2 By Country, North America Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share
7.4 Europe
7.4.1 Europe Major Histocompatibility Complex (MHC) Tetramer Market Size & Forecasts, 2020-2031
7.4.2 By Country, Europe Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Major Histocompatibility Complex (MHC) Tetramer Market Size & Forecasts, 2020-2031
7.5.2 By Country/Region, Asia Pacific Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share
7.6 South America
7.6.1 South AmericaMajor Histocompatibility Complex (MHC) Tetramer Market Size & Forecasts, 2020-2031
7.6.2 By Country, South America Major Histocompatibility Complex (MHC) Tetramer Market Size Market Share
7.7 Middle East & Africa

8 Sales Sights by Country Level
8.1 By Country, Global Major Histocompatibility Complex (MHC) Tetramer Market Size & CAGR, 2020 VS 2024 VS 2031
8.2 By Country, Global Major Histocompatibility Complex (MHC) Tetramer Consumption Value, 2020-2031
8.3 United States
8.3.1 United States Major Histocompatibility Complex (MHC) Tetramer Market Size, 2020-2031
8.3.2 by Type, United States Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.3.3 by Application, United States Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.4 Europe
8.4.1 Europe Major Histocompatibility Complex (MHC) Tetramer Market Size, 2020-2031
8.4.2 by Type, Europe Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.4.3 by Application, Europe Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.5 China
8.5.1 China Major Histocompatibility Complex (MHC) Tetramer Market Size, 2020-2031
8.5.2 by Type, China Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.5.3 by Application, China Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.6 Japan
8.6.1 Japan Major Histocompatibility Complex (MHC) Tetramer Market Size, 2020-2031
8.6.2 by Type, Japan Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.6.3 by Application, Japan Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.7 South Korea
8.7.1 South Korea Major Histocompatibility Complex (MHC) Tetramer Market Size, 2020-2031
8.7.2 by Type, South Korea Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.7.3 by Application, South Korea Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.8 Southeast Asia
8.8.1 Southeast Asia Major Histocompatibility Complex (MHC) Tetramer Market Size, 2020-2031
8.8.2 by Type, Southeast Asia Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.8.3 by Application, Southeast Asia Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.9 India
8.9.1 India Major Histocompatibility Complex (MHC) Tetramer Market Size, 2020-2031
8.9.2 by Type, India Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.9.3 by Application, India Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.10 Middle East & Africa
8.10.1 Middle East & Africa Major Histocompatibility Complex (MHC) Tetramer Market Size, 2020-2031
8.10.2 by Type, Middle East & Africa Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031
8.10.3 by Application, Middle East & Africa Major Histocompatibility Complex (MHC) Tetramer Consumption Value Market Share, 2024 VS 2031

9 Company Profile
9.1 MBL Life Science
9.1.1 MBL Life Science Company Information, Head Office, Market Area, and Industry Position
9.1.2 MBL Life Science Company Profile and Main Business
9.1.3 MBL Life Science Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
9.1.4 MBL Life Science Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2020-2025
9.1.5 MBL Life Science Recent Developments
9.2 ProImmune
9.2.1 ProImmune Company Information, Head Office, Market Area, and Industry Position
9.2.2 ProImmune Company Profile and Main Business
9.2.3 ProImmune Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
9.2.4 ProImmune Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2020-2025
9.2.5 ProImmune Recent Developments
9.3 BioLegend
9.3.1 BioLegend Company Information, Head Office, Market Area, and Industry Position
9.3.2 BioLegend Company Profile and Main Business
9.3.3 BioLegend Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
9.3.4 BioLegend Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2020-2025
9.3.5 BioLegend Recent Developments
9.4 KACTUS
9.4.1 KACTUS Company Information, Head Office, Market Area, and Industry Position
9.4.2 KACTUS Company Profile and Main Business
9.4.3 KACTUS Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
9.4.4 KACTUS Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2020-2025
9.4.5 KACTUS Recent Developments
9.5 Creative Biolabs
9.5.1 Creative Biolabs Company Information, Head Office, Market Area, and Industry Position
9.5.2 Creative Biolabs Company Profile and Main Business
9.5.3 Creative Biolabs Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
9.5.4 Creative Biolabs Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2020-2025
9.5.5 Creative Biolabs Recent Developments
9.6 immunAware
9.6.1 immunAware Company Information, Head Office, Market Area, and Industry Position
9.6.2 immunAware Company Profile and Main Business
9.6.3 immunAware Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
9.6.4 immunAware Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2020-2025
9.6.5 immunAware Recent Developments
9.7 HELIXGEN
9.7.1 HELIXGEN Company Information, Head Office, Market Area, and Industry Position
9.7.2 HELIXGEN Company Profile and Main Business
9.7.3 HELIXGEN Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
9.7.4 HELIXGEN Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2020-2025
9.7.5 HELIXGEN Recent Developments
9.8 ACROBiosystems
9.8.1 ACROBiosystems Company Information, Head Office, Market Area, and Industry Position
9.8.2 ACROBiosystems Company Profile and Main Business
9.8.3 ACROBiosystems Major Histocompatibility Complex (MHC) Tetramer Models, Specifications, and Application
9.8.4 ACROBiosystems Major Histocompatibility Complex (MHC) Tetramer Revenue and Gross Margin, 2020-2025
9.8.5 ACROBiosystems Recent Developments

10 Conclusion

11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

According to YH Research, the global market for Major Histocompatibility Complex (MHC) Tetramer should grow from US$ 12.6 million in 2024 to US$ 21.4 million by 2031, with a CAGR of 7.7% for the period of 2025-2031.

An MHC tetramer is a laboratory tool used to study antigen-specific T cells. It consists of four major histocompatibility complex (MHC) molecules bound to a specific peptide and labeled with a fluorescent tag. These tetramers can bind to T cell receptors (TCRs) on the surface of T cells that recognize the specific peptide-MHC complex. By using flow cytometry, researchers can identify and quantify antigen-specific T cells, making MHC tetramers a valuable tool for immunological studies, including vaccine development, cancer immunotherapy, and infectious disease research.

Major Histocompatibility Complex (MHC) Tetramer

Unit: US$ M

www.yhresearch.com

In-depth insight into market trends

In 2023, North America accounted for the largest sales share of the MHC tetramer market. The region is characterized by a large number of pharmaceutical R&D service providers. Meanwhile, Asia Pacific is expected to witness the highest CAGR during the forecast period.

The major global companies of Major Histocompatibility Complex (MHC) Tetramer include MBL Life Science, ProImmune, BioLegend, KACTUS, Creative Biolabs, immunAware, HELIXGEN, ACROBiosystems and etc. In 2023, the world's top three vendors accounted for approximately 56.50% of the revenue.

In terms of application, the continued research demand for cancer immunotherapy and adoptive T cell therapy and immune responses to emerging and re-emerging viral infectious diseases such as COVID-19, HIV and influenza is the main reason driving the MHC tetramer market. In 2023, MHC tetramers for cancer research accounted for approximately 48.00% of the market.

Currently, the MHC tetramer market mainly consists of two types: MHC-I and MHC-II. MHC-I is mainly used for research on cancer, viruses, bacteria, etc., and MHC-II is mainly used for research on viruses, bacteria, allergens, etc. In 2023, the sales of MHC-I and MHC-II will be US$6.63 million and US$4.29 million, respectively.

This report studies and analyses global Major Histocompatibility Complex (MHC) Tetramer status and future trends, to help determine the Major Histocompatibility Complex (MHC) Tetramer market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Major Histocompatibility Complex (MHC) Tetramer, and provides market size (US$ million) and Year-over-Year growth, considering 2024 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights
(1) Global Major Histocompatibility Complex (MHC) Tetramer market size, history data 2020-2025, and forecast data 2026 -2031, (US$ million)
(2) Global Major Histocompatibility Complex (MHC) Tetramer by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(3) China Major Histocompatibility Complex (MHC) Tetramer by company, revenue, market share and industry ranking 2020-2025, (US$ million)
(4) Global Major Histocompatibility Complex (MHC) Tetramer key consuming regions, consumption value and demand structure
(5) Major Histocompatibility Complex (MHC) Tetramer industry chains, upstream, midstream and downstream
Market segment by players, this report covers
MBL Life Science
ProImmune
BioLegend
KACTUS
Creative Biolabs
immunAware
HELIXGEN
ACROBiosystems

Market segment by Type, covers
MHC-I
MHC-II

Market segment by Application, can be divided into
Cancer research
Virus research
Bacteria research
Other

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Major Histocompatibility Complex (MHC) Tetramer product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.
Chapter 2: Global Major Histocompatibility Complex (MHC) Tetramer market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 3: China Major Histocompatibility Complex (MHC) Tetramer market share and ranking of major manufacturers, revenue, 2020-2025
Chapter 4: Major Histocompatibility Complex (MHC) Tetramer industry chain, upstream, medium-stream, and downstream.
Chapter 5: Segment by Type, consumption value, percent & CAGR, 2020-2031
Chapter 6: Segment by Application, consumption value, percent & CAGR, 2020-2031
Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2020-2031
Chapter 8: Segment in country level, consumption value, percent & CAGR, 2020-2031
Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.
Chapter 10: Conclusions